Good posts. I thought you also agreed the particularly "provable" nefarious behaviour was however they managed to get Reuters to post the standard risk disclaimers in isolation as a hot news item.
I would love to know how that happened. Hopefully people didn't lose too much due to that. I haven't sold and don't get too worried about shorters much any more, although I 100% try to understand their point of view as it's a tough gig and they are often right. In this case as you state I don't believe their view stacks up, and it let me get more stock cheaper! Maybe in our case the market views them as correct before as many seem to believe the stock was/is overvalued despite a huge amount going into growth. (r&d/sales) Maybe the new CFO might be able to constrain the spending a little.
ACX Price at posting:
$4.00 Sentiment: Buy Disclosure: Held